The Startup Selling Full-Body Scans as the Future of Health Care
Step into the machine at Neko Health or one of its rivals to check for skin cancer, diabetes or stroke risk. Is this the next frontier in preventative health care, or something your primary care physician would rather you avoid?
Neko founders Hjalmar Nilsonne and Daniel Ek.
Source: Neko HealthIt’s been 15 years since Spotify co-founder Daniel Ek brought the streaming platform to the US, changing the way Americans discover and consume music. His next project—a startup that offers full-body health scans—will soon arrive stateside with its own ambitious plans to reshape an industry.
Neko Health, founded in 2018 as Ek began planning for life after Spotify Technology SA’s initial public offering, operates in Sweden and the UK. If Neko receives regulatory approval in the US, something it’s working through now, the company’s first American location will open in New York as soon as this spring, with more US clinics planned in the following months, says Chief Executive Officer Hjalmar Nilsonne. In the UK, the company’s full-body health scans—which use a combination of imaging and other tests, including a blood test, to check for conditions such as skin cancer, heart disease and diabetes risk—cost £299 (about $400); Nilsonne says the price in the US will likely be higher due to greater costs for medical staffing and real estate.